Alberto Bardelli

Alberto Bardelli is an accomplished professional specializing in the molecular basis of targeted cancer therapies, liquid biopsies, cancer immunogenomics, DNA repair, neoantigens, and mutation-specific pharmacogenomic profiling.

His educational journey includes a Board Certified specialist in Clinical Pathology from the University of Torino School of Medicine, a PhD in Biochemistry and Molecular Biology from University College London (UCL) at Ludwig Institute for Cancer Research, and a Postdoctoral fellowship in Cancer Genetics from The Johns Hopkins University School of Medicine.

Alberto Bardelli's expertise extends to mutational analysis of cancer genes, cellular models of tumor progression, and genetic dissection of oncogenic signaling pathways.

He holds a position as a Full Professor at the Department of Oncology at the University of Torino and has had leadership roles such as President at the European Association for Cancer Research (EACR) and Director of Basic Research at Candiolo Cancer Institute IRCCS.

Additionally, he has served as a Group Leader-Director and an Associate Professor at Candiolo Cancer Institute IRCCS.